col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


32 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Blood Cancer Journal
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Okt―21 Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study Niels W. C. J. van de Donk, Nizar Bahlis, Luciano J. Costa, María-Victoria Mateos, Ajay K. Nooka, Aurore Perrot, et al. (+7)
2 [GO] 2024―Jul―10 Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19 Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Catarina Maia, et al. (+16)
3 [GO] 2024―Jan―25 Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia Thomas Roberts, Grace Uwenedi, Rachel Bruton, Graham McIlroy, Sarah Damery, Panagiota Sylla, et al. (+15)
4 [GO] 2023―Dez―07 Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, et al. (+10)
5 [GO] 2023―Sep―05 Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease Daisuke Ikeda, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Kentaro Narita, et al. (+4)
6 [GO] 2023―Jul―26 In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms Emily Ayers, Glenda Canderan, Michael E. Williams, Behnam Keshavarz, Craig A. Portell, Jeffrey M. Wilson, Judith A. Woodfolk
7 [GO] 2023―Apr―10 Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients Ahmad Alcheikh, Griffith B. Perkins, Phillippa A. Pucar, Amelia Cecchin, Cheng Sheng Chai, Matthew Tunbridge, et al. (+9)
8 [GO] 2023―Mrz―15 Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic Jonathan Carmichael, Frances Seymour, Graham McIlroy, Sarrah Tayabali, Rosie Amerikanou, Sylvia Feyler, et al. (+6)
9 [GO] 2023―Jan―23 Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Satoshi Yoshioka, Hayato Maruoka, Seiko Nasu, et al. (+15)
10 [GO] 2023―Jan―05 One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, et al. (+26)
11 [GO] 2022―Dez―23 Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, Thita Chiasakul, Ponlapat Rojnuckarin
12 [GO] 2022―Nov―24 Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, et al. (+24)
13 [GO] 2022―Nov―23 The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas J. Boddicker, Janet E. Olson, et al. (+8)
14 [GO] 2022―Mai―31 Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review Vanessa Piechotta, Sibylle C. Mellinghoff, Caroline Hirsch, Alice Brinkmann, Claire Iannizzi, Nina Kreuzberger, et al. (+6)
15 [GO] 2022―Apr―22 Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib Patrick Harrington, Katie J. Doores, Jamie Saunders, Marc de Lord, Chandan Saha, Thomas Lechmere, et al. (+15)
16 [GO] 2022―Jan―18 Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients Cinzia Borgogna, Riccardo Bruna, Gloria Griffante, Licia Martuscelli, Marco De Andrea, Daniela Ferrante, et al. (+11)
17 [GO] 2022―Jan―12 Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning L. M. Morsink, J. van Doesum, G. Choi, C. L. E. Hazenberg, A. Biswana, F. Meppelink, et al. (+3)
18 [GO] 2022―Jan―05 Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, et al. (+21)
19 [GO] 2021―Dez―14 SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma Nicola Sgherza, Paola Curci, Rita Rizzi, Immacolata Attolico, Daniela Loconsole, Anna Mestice, et al. (+2)
20 [GO] 2021―Dez―14 Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, Anastasiia Zherniakova, Camila Guerrero, Aintzane Zabaleta, et al. (+16)
21 [GO] 2021―Dez―10 Impact of COVID-19 in patients with multiple myeloma based on a global data network J. Martinez-Lopez, G. Hernandez-Ibarburu, R. Alonso, J. M. Sanchez-Pina, I. Zamanillo, N. Lopez-Muñoz, et al. (+12)
22 [GO] 2021―Dez―01 Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study Saemundur Rognvaldsson, Elias Eythorsson, Sigrun Thorsteinsdottir, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni A. Agnarsson, et al. (+23)
23 [GO] 2021―Nov―30 Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience Daniele Cattaneo, Cristina Bucelli, Francesca Cavallaro, Dario Consonni, Alessandra Iurlo
24 [GO] 2021―Nov―29 Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism Marko Lucijanic, Ivan Krecak, Ena Soric, Martina Sedinic, Anica Sabljic, Lovorka Derek, et al. (+2)
25 [GO] 2021―Sep―14 Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab C. Cattaneo, V. Cancelli, L. Imberti, K. Dobbs, A. Sottini, C. Pagani, et al. (+11)
26 [GO] 2021―Aug―10 Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies Florent Malard, Béatrice Gaugler, Joel Gozlan, Lucie Bouquet, Djeneba Fofana, Lama Siblany, et al. (+20)
27 [GO] 2021―Aug―02 The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+10)
28 [GO] 2021―Jul―30 Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia H. Parry, G. McIlroy, R. Bruton, M. Ali, C. Stephens, S. Damery, et al. (+11)
29 [GO] 2021―Jul―14 Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital Nicolas Vallet, Sylvie Chevret, Linda Feghoul, Lorea Aguinaga, Louise Bondeelle, Eleonore Kaphan, et al. (+21)
30 [GO] 2021―Jun―16 Long-term follow-up of recovered MPN patients with COVID-19 Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Giuseppe Rossi, et al. (+46)
31 [GO] 2021―Feb―09 Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 Tiziano Barbui, Valerio De Stefano, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, et al. (+45)
32 [GO] 2020―Okt―19 Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality Joaquín Martínez-López, María-Victoria Mateos, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, et al. (+19)
 [1] 

32 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec